Business Description
CH BIOTECH R&D CO LTD
ISIN : TW0006534001
Compare
Compare
Traded in other countries / regions
6534.Taiwan IPO Date
2015-07-02Description
CH BIOTECH R&D CO LTD is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, & sales of proprietary plant growth regulators & specialty micronutrient fertilizers. Its products include nutrient Efficiency Stress Reduction, Plant Growth Promotion, Crop Fruit Quality, Plant Derived Biotechnology. Geographically it generates the majority of its revenue from the United States.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.01 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.33 | |||||
| Debt-to-EBITDA | 1.06 | |||||
| Interest Coverage | 35.99 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 4.81 | |||||
| Beneish M-Score | -1.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 29.1 | |||||
| 3-Year EBITDA Growth Rate | 45.2 | |||||
| 3-Year EPS without NRI Growth Rate | 66.3 | |||||
| 3-Year FCF Growth Rate | 63.4 | |||||
| 3-Year Book Growth Rate | 17.2 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.34 | |||||
| 9-Day RSI | 63.93 | |||||
| 14-Day RSI | 61.3 | |||||
| 6-1 Month Momentum % | -2.24 | |||||
| 12-1 Month Momentum % | 4.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.35 | |||||
| Quick Ratio | 1.27 | |||||
| Cash Ratio | 0.79 | |||||
| Days Inventory | 164.23 | |||||
| Days Sales Outstanding | 51.43 | |||||
| Days Payable | 10.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.53 | |||||
| Dividend Payout Ratio | 0.87 | |||||
| 3-Year Dividend Growth Rate | 72.1 | |||||
| Forward Dividend Yield % | 4.53 | |||||
| 5-Year Yield-on-Cost % | 10.58 | |||||
| 3-Year Average Share Buyback Ratio | -1.9 | |||||
| Shareholder Yield % | 5.66 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 84.14 | |||||
| Operating Margin % | 37.58 | |||||
| Net Margin % | 31.81 | |||||
| FCF Margin % | 10.34 | |||||
| ROE % | 20.88 | |||||
| ROA % | 13.5 | |||||
| ROIC % | 16.18 | |||||
| ROC (Joel Greenblatt) % | 26.11 | |||||
| ROCE % | 22.52 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.07 | |||||
| PE Ratio without NRI | 19.1 | |||||
| Shiller PE Ratio | 23.5 | |||||
| Price-to-Owner-Earnings | 44.4 | |||||
| PEG Ratio | 1.11 | |||||
| PS Ratio | 5.92 | |||||
| PB Ratio | 3.52 | |||||
| Price-to-Tangible-Book | 3.53 | |||||
| Price-to-Free-Cash-Flow | 53.47 | |||||
| Price-to-Operating-Cash-Flow | 13.19 | |||||
| EV-to-EBIT | 14.54 | |||||
| EV-to-EBITDA | 11.45 | |||||
| EV-to-Revenue | 6.02 | |||||
| EV-to-FCF | 58.28 | |||||
| Price-to-Projected-FCF | 2.87 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.11 | |||||
| Price-to-Graham-Number | 1.73 | |||||
| Earnings Yield (Greenblatt) % | 6.88 | |||||
| FCF Yield % | 1.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CH BIOTECH R&D CO LTD Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,538.782 | ||
| EPS (TTM) (NT$) | 4.73 | ||
| Beta | 0.66 | ||
| Volatility % | 42.13 | ||
| 14-Day RSI | 61.3 | ||
| 14-Day ATR (NT$) | 2.01178 | ||
| 20-Day SMA (NT$) | 85.74 | ||
| 12-1 Month Momentum % | 4.14 | ||
| 52-Week Range (NT$) | 71.7 - 114.5 | ||
| Shares Outstanding (Mil) | 102.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CH BIOTECH R&D CO LTD Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CH BIOTECH R&D CO LTD Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
CH BIOTECH R&D CO LTD Frequently Asked Questions
What is CH BIOTECH R&D CO LTD(TPE:6534)'s stock price today?
The current price of TPE:6534 is NT$90.20. The 52 week high of TPE:6534 is NT$114.50 and 52 week low is NT$71.70.
When is next earnings date of CH BIOTECH R&D CO LTD(TPE:6534)?
The next earnings date of CH BIOTECH R&D CO LTD(TPE:6534) is .
Does CH BIOTECH R&D CO LTD(TPE:6534) pay dividends? If so, how much?
The Dividend Yield %  of CH BIOTECH R&D CO LTD(TPE:6534) is 4.53% (As of Today), Highest Dividend Payout Ratio of CH BIOTECH R&D CO LTD(TPE:6534) was 1.03. The lowest was 0.14. And the median was 0.49. The  Forward Dividend Yield % of CH BIOTECH R&D CO LTD(TPE:6534) is 4.53%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers